AU3060400A - Triazole and tetrazole derivatives, and their therapeutic use - Google Patents

Triazole and tetrazole derivatives, and their therapeutic use

Info

Publication number
AU3060400A
AU3060400A AU30604/00A AU3060400A AU3060400A AU 3060400 A AU3060400 A AU 3060400A AU 30604/00 A AU30604/00 A AU 30604/00A AU 3060400 A AU3060400 A AU 3060400A AU 3060400 A AU3060400 A AU 3060400A
Authority
AU
Australia
Prior art keywords
triazole
therapeutic use
tetrazole derivatives
tetrazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30604/00A
Inventor
Jean Bertin
Philippe R Bovy
Gilles Courtemanche
Olivier Crespin
Gerard Defosse
Eykmar Fett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU3060400A publication Critical patent/AU3060400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU30604/00A 1999-02-02 2000-01-28 Triazole and tetrazole derivatives, and their therapeutic use Abandoned AU3060400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9901143A FR2789077A1 (en) 1999-02-02 1999-02-02 PERAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR9901143 1999-02-02
PCT/FR2000/000191 WO2000046220A1 (en) 1999-02-02 2000-01-28 Triazole and tetrazole derivatives, and their therapeutic use

Publications (1)

Publication Number Publication Date
AU3060400A true AU3060400A (en) 2000-08-25

Family

ID=9541473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30604/00A Abandoned AU3060400A (en) 1999-02-02 2000-01-28 Triazole and tetrazole derivatives, and their therapeutic use

Country Status (6)

Country Link
EP (1) EP1150972A1 (en)
JP (1) JP2002539085A (en)
AU (1) AU3060400A (en)
CO (1) CO5140090A1 (en)
FR (1) FR2789077A1 (en)
WO (1) WO2000046220A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811989A1 (en) * 2000-07-18 2002-01-25 Sanofi Synthelabo POLYFLUOROALKYTRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
EP1458381B1 (en) 2001-12-20 2005-11-30 Applied Research Systems ARS Holding N.V. Triazoles as oxytocin antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263213B1 (en) * 1986-10-09 1995-09-06 The Upjohn Company C20 Through C26 amino steroids
US4610717A (en) * 1985-11-26 1986-09-09 Shell Oil Company Certain 5-(R-oxy)-1-phenyl or (3-(trifluoromethyl)phenyl)triazoles, useful for controlling undesired plant growth
US5438149A (en) * 1994-05-27 1995-08-01 Fmc Corporation Difluoromethylation of a phenyl triazolinone
FR2751647B1 (en) * 1996-07-25 1998-09-11 Synthelabo BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
JP2002539085A (en) 2002-11-19
WO2000046220A1 (en) 2000-08-10
CO5140090A1 (en) 2002-03-22
EP1150972A1 (en) 2001-11-07
FR2789077A1 (en) 2000-08-04

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU3956900A (en) Substituted imidazoles, their preparation and use
AU5760900A (en) Multiple agent diabetes therapy
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU3033100A (en) Substituted imidazoles, their preparation and use
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
ZA200003680B (en) Triazole and imidazole derivatives.
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU715620C (en) Therapeutic methods and uses
HUP0201874A2 (en) Pesticidal indazole and benzotriazole derivatives, preparation and use thereof
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU2451500A (en) Therapeutic agents
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU3978700A (en) Medical use
AU5973600A (en) Therapeutic agents
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU3060400A (en) Triazole and tetrazole derivatives, and their therapeutic use
AU1043601A (en) Medical use
AU2001275696A1 (en) Therapeutic agent
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU6150200A (en) Therapeutic agents
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
AU7919100A (en) Clear hair-treatment agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase